The DOI matches its Crossref record; 186 of the 186 references it cites were found in a registry or an index.
Lung cancer mutation profile of EGFR, ALK, and KRAS: Meta-analysis and comparison of never and ever smokers
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: the PRISMA statement
Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G., & for the PRISMA Group (2009) · BMJ · doi:10.1136/bmj.b2535 · Cited by 83,823
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement.
(2009) · PubMed Central · Cited by 44,859
Meta-analysis in clinical trials
DerSimonian, R., & Laird, N. (1986) · Controlled Clinical Trials · doi:10.1016/0197-2456(86)90046-2 · Cited by 39,552
Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement
Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G., & the PRISMA Group* (2009) · Annals of Internal Medicine · doi:10.7326/0003-4819-151-4-200908180-00135 · Cited by 37,554
Quantifying heterogeneity in a meta‐analysis
Higgins, J. P. T., & Thompson, S. G. (2002) · Statistics in Medicine · doi:10.1002/sim.1186 · Cited by 36,763
Conducting Meta-Analyses in R with the metafor Package
Viechtbauer, W. (2010) · Journal of Statistical Software · doi:10.18637/jss.v036.i03 · Cited by 20,464
Gefitinib or Carboplatin–Paclitaxel in Pulmonary Adenocarcinoma
Mok, T. S., Wu, Y.-L., Thongprasert, S., Yang, C.-H., Chu, D.-T., Saijo, N., Sunpaweravong, P., Han, B., Margono, B., Ichinose, Y., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0810699 · Cited by 8,261
Rosell, R., Carcereny, E., Gervais, R., Vergnenegre, A., Massuti, B., Felip, E., Palmero, R., Garcia-Gomez, R., Pallares, C., Sanchez, J. M., et al. (2012) · The Lancet Oncology · doi:10.1016/s1470-2045(11)70393-x · Cited by 5,489
Identification of the transforming EML4–ALK fusion gene in non-small-cell lung cancer
Soda, M., Choi, Y. L., Enomoto, M., Takada, S., Yamashita, Y., Ishikawa, S., Fujiwara, S.-I., Watanabe, H., Kurashina, K., Hatanaka, H., et al. (2007) · Nature · doi:10.1038/nature05945 · Cited by 5,439
Pao, W., Miller, V., Zakowski, M., Doherty, J., Politi, K., Sarkaria, I., Singh, B., Heelan, R., Rusch, V., Fulton, L., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0405220101 · Cited by 4,338
Shigematsu, H., Lin, L., Takahashi, T., Nomura, M., Suzuki, M., Wistuba, I. I., Fong, K. M., Lee, H., Toyooka, S., Shimizu, N., et al. (2005) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/dji055 · Cited by 2,377
Screening for Epidermal Growth Factor Receptor Mutations in Lung Cancer
Rosell, R., Moran, T., Queralt, C., Porta, R., Cardenal, F., Camps, C., Majem, M., Lopez-Vivanco, G., Isla, D., Provencio, M., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0904554 · Cited by 2,373
Publication Bias in Meta‐Analysis: Prevention, Assessment and Adjustments
(2005) · doi:10.1002/0470870168 · Cited by 2,368
ROS1 Rearrangements Define a Unique Molecular Class of Lung Cancers
Bergethon, K., Shaw, A. T., Ignatius Ou, S.-H., Katayama, R., Lovly, C. M., McDonald, N. T., Massion, P. P., Siwak-Tapp, C., Gonzalez, A., Fang, R., et al. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2011.35.6345 · Cited by 1,555
Cappuzzo, F., Hirsch, F. R., Rossi, E., Bartolini, S., Ceresoli, G. L., Bemis, L., Haney, J., Witta, S., Danenberg, K., Domenichini, I., et al. (2005) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/dji112 · Cited by 1,551
Shi, Y., Au, J. S.-K., Thongprasert, S., Srinivasan, S., Tsai, C.-M., Khoa, M. T., Heeroma, K., Itoh, Y., Cornelio, G., & Yang, P.-C. (2014) · Journal of Thoracic Oncology · doi:10.1097/jto.0000000000000033 · Cited by 1,551
Lindeman, N. I., Cagle, P. T., Beasley, M. B., Chitale, D. A., Dacic, S., Giaccone, G., Jenkins, R. B., Kwiatkowski, D. J., Saldivar, J.-S., Squire, J., et al. (2013) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e318290868f · Cited by 1,280
Viechtbauer, W. (2007) · Psychometrika · doi:10.1007/s11336-006-1450-y · Cited by 1,250
Barlesi, F., Mazieres, J., Merlio, J.-P., Debieuvre, D., Mosser, J., Lena, H., Ouafik, L., Besse, B., Rouquette, I., Westeel, V., et al. (2016) · The Lancet · doi:10.1016/s0140-6736(16)00004-0 · Cited by 1,004
EML4-ALK Fusion Gene and Efficacy of an ALK Kinase Inhibitor in Lung Cancer
Koivunen, J. P., Mermel, C., Zejnullahu, K., Murphy, C., Lifshits, E., Holmes, A. J., Choi, H. G., Kim, J., Chiang, D., Thomas, R., et al. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-0168 · Cited by 993
Lung cancer in never smokers – A review
Couraud, S., Zalcman, G., Milleron, B., Morin, F., & Souquet, P.-J. (2012) · European Journal of Cancer · doi:10.1016/j.ejca.2012.03.007 · Cited by 960
Okayama, H., Kohno, T., Ishii, Y., Shimada, Y., Shiraishi, K., Iwakawa, R., Furuta, K., Tsuta, K., Shibata, T., Yamamoto, S., et al. (2012) · Cancer Research · doi:10.1158/0008-5472.can-11-1403 · Cited by 874
Marchetti, A., Martella, C., Felicioni, L., Barassi, F., Salvatore, S., Chella, A., Camplese, P. P., Iarussi, T., Mucilli, F., Mezzetti, A., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.08.043 · Cited by 788
Han, S.-W., Kim, T.-Y., Hwang, P. G., Jeong, S., Kim, J., Choi, I. S., Oh, D.-Y., Kim, J. H., Kim, D.-W., Chung, D. H., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.01.388 · Cited by 768
Wong, D. W., Leung, E. L., So, K. K., Tam, I. Y., Sihoe, A. D., Cheng, L., Ho, K., Au, J. S., Chung, L., Pik Wong, M., et al. (2009) · Cancer · doi:10.1002/cncr.24181 · Cited by 719
The power of statistical tests in meta-analysis
Hedges, L. V., & Pigott, T. D. (2001) · Psychological Methods · doi:10.1037/1082-989x.6.3.203 · Cited by 716
Clinical Characteristics of Patients With Lung Adenocarcinomas Harboring BRAF Mutations
Paik, P. K., Arcila, M. E., Fara, M., Sima, C. S., Miller, V. A., Kris, M. G., Ladanyi, M., & Riely, G. J. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.33.1280 · Cited by 691
Lung Cancer in Never Smokers: A Review
Subramanian, J., & Govindan, R. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.06.8015 · Cited by 655
Dogan, S., Shen, R., Ang, D. C., Johnson, M. L., D'Angelo, S. P., Paik, P. K., Brzostowski, E. B., Riely, G. J., Kris, M. G., Zakowski, M. F., et al. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-3265 · Cited by 639
Inoue, A., Suzuki, T., Fukuhara, T., Maemondo, M., Kimura, Y., Morikawa, N., Watanabe, H., Saijo, Y., & Nukiwa, T. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.05.4692 · Cited by 509
Tokumo, M., Toyooka, S., Kiura, K., Shigematsu, H., Tomii, K., Aoe, M., Ichimura, K., Tsuda, T., Yano, M., Tsukuda, K., et al. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.1167.11.3 · Cited by 490
Ahrendt, S. A., Decker, P. A., Alawi, E. A., Zhu, Y.-R., Sanchez-Cespedes, M., Yang, S. C., Haasler, G. B., Kajdacsy-Balla, A., Demeure, M. J., & Sidransky, D. (2001) · Cancer · doi:10.1002/1097-0142(20010915)92:6<1525::aid-cncr1478>3.0.co;2-h · Cited by 449
Inamura, K., Takeuchi, K., Togashi, Y., Hatano, S., Ninomiya, H., Motoi, N., Mun, M.-Y., Sakao, Y., Okumura, S., Nakagawa, K., et al. (2009) · Modern Pathology · doi:10.1038/modpathol.2009.2 · Cited by 445
Douillard, J.-Y., Ostoros, G., Cobo, M., Ciuleanu, T., McCormack, R., Webster, A., & Milenkova, T. (2014) · British Journal of Cancer · doi:10.1038/bjc.2013.721 · Cited by 412
Tam, I. Y. S., Chung, L. P., Suen, W. S., Wang, E., Wong, M. C. M., Ho, K. K., Lam, W. K., Chiu, S. W., Girard, L., Minna, J. D., et al. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-1981 · Cited by 400
Natural History and Molecular Characteristics of Lung Cancers Harboring EGFR Exon 20 Insertions
Oxnard, G. R., Lo, P. C., Nishino, M., Dahlberg, S. E., Lindeman, N. I., Butaney, M., Jackman, D. M., Johnson, B. E., & Jänne, P. A. (2013) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e3182779d18 · Cited by 360
Clinical significance of ras oncogene activation in human lung cancer
(1993) · Lung Cancer · doi:10.1016/0169-5002(93)90536-7 · Cited by 360
Sun, Y., Ren, Y., Fang, Z., Li, C., Fang, R., Gao, B., Han, X., Tian, W., Pao, W., Chen, H., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2010.29.6038 · Cited by 335
Taron, M., Ichinose, Y., Rosell, R., Mok, T., Massuti, B., Zamora, L., Mate, J. L., Manegold, C., Ono, M., Queralt, C., et al. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-2618 · Cited by 334
Clinicopathologic Features of Non-Small-Cell Lung Cancer with EML4–ALK Fusion Gene
Takahashi, T., Sonobe, M., Kobayashi, M., Yoshizawa, A., Menju, T., Nakayama, E., Mino, N., Iwakiri, S., Sato, K., Miyahara, R., et al. (2010) · Annals of Surgical Oncology · doi:10.1245/s10434-009-0808-7 · Cited by 326
EML4-ALK Rearrangement in Non-Small Cell Lung Cancer and Non-Tumor Lung Tissues
Martelli, M. P., Sozzi, G., Hernandez, L., Pettirossi, V., Navarro, A., Conte, D., Gasparini, P., Perrone, F., Modena, P., Pastorino, U., et al. (2009) · The American Journal of Pathology · doi:10.2353/ajpath.2009.080755 · Cited by 317
D'Angelo, S. P., Pietanza, M. C., Johnson, M. L., Riely, G. J., Miller, V. A., Sima, C. S., Zakowski, M. F., Rusch, V. W., Ladanyi, M., & Kris, M. G. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.32.6181 · Cited by 301
Zhang, X., Zhang, S., Yang, X., Yang, J., Zhou, Q., Yin, L., An, S., Lin, J., Chen, S., Xie, Z., et al. (2010) · Molecular Cancer · doi:10.1186/1476-4598-9-188 · Cited by 296
Mutations and addiction to EGFR: the Achilles ‘heal’ of lung cancers?
Gazdar, A. F., Shigematsu, H., Herz, J., & Minna, J. D. (2004) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2004.08.008 · Cited by 293
Comparison of aspects of smoking among the four histological types of lung cancer
Kenfield, S. A., Wei, E. K., Stampfer, M. J., Rosner, B. A., & Colditz, G. A. (2008) · Tobacco Control · doi:10.1136/tc.2007.022582 · Cited by 289
Le Calvez, F., Mukeria, A., Hunt, J. D., Kelm, O., Hung, R. J., Tanière, P., Brennan, P., Boffetta, P., Zaridze, D. G., & Hainaut, P. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-0551 · Cited by 273
Bai, H., Mao, L., Wang, H. S., Zhao, J., Yang, L., An, T. T., Wang, X., Duan, C. J., Wu, N. M., Guo, Z. Q., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.17.3930 · Cited by 273
Kosaka, T., Yatabe, Y., Onozato, R., Kuwano, H., & Mitsudomi, T. (2009) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e3181914111 · Cited by 254
Li, S., Li, L., Zhu, Y., Huang, C., Qin, Y., Liu, H., Ren-Heidenreich, L., Shi, B., Ren, H., Chu, X., et al. (2014) · British Journal of Cancer · doi:10.1038/bjc.2014.210 · Cited by 243
Cortes-Funes, H., Gomez, C., Rosell, R., Valero, P., Garcia-Giron, C., Velasco, A., Izquierdo, A., Diz, P., Camps, C., Castellanos, D., et al. (2005) · Annals of Oncology · doi:10.1093/annonc/mdi221 · Cited by 230
Implications and Prognostic Value of K-ras Mutation for Early-Stage Lung Cancer in Women
Nelson, H. H., Christiani, D. C., Mark, E. J., Wiencke, J. K., Wain, J. C., & Kelsey, K. T. (1999) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/91.23.2032 · Cited by 227
Lung cancer epigenetics and genetics
Risch, A., & Plass, C. (2008) · International Journal of Cancer · doi:10.1002/ijc.23605 · Cited by 220
Pham, D., Kris, M. G., Riely, G. J., Sarkaria, I. S., McDonough, T., Chuai, S., Venkatraman, E. S., Miller, V. A., Ladanyi, M., Pao, W., et al. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.04.3224 · Cited by 212
Relationship Between K-ras Oncogene Activation and Smoking in Adenocarcinoma of the Human Lung
Slebos, R. J. C., Hruban, R. H., Dalesio, O., Mooi, W. J., Offerhaus, G. J. A., & Rodenhuis, S. (1991) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/83.14.1024 · Cited by 202
Relationship between K-ras oncogene activation and smoking in adenocarcinoma of the human lung
(1992) · Lung Cancer · doi:10.1016/0169-5002(92)90232-9 · Cited by 187
Wu, Y.-L., Zhong, W.-Z., Li, L.-Y., Zhang, X.-T., Zhang, L., Zhou, C.-C., Liu, W., Jiang, B., Mu, X.-L., Lin, J.-Y., et al. (2007) · Journal of Thoracic Oncology · doi:10.1097/01.jto.0000268677.87496.4c · Cited by 186
D’Angelo, S. P., Janjigian, Y. Y., Ahye, N., Riely, G. J., Chaft, J. E., Sima, C. S., Shen, R., Zheng, J., Dycoco, J., Kris, M. G., et al. (2012) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e31826bb7b2 · Cited by 183
Frequency of and variables associated with the EGFR mutation and its subtypes
Tanaka, T., Matsuoka, M., Sutani, A., Gemma, A., Maemondo, M., Inoue, A., Okinaga, S., Nagashima, M., Oizumi, S., Uematsu, K., et al. (2010) · International Journal of Cancer · doi:10.1002/ijc.24746 · Cited by 183
Ludovini, V., Bianconi, F., Pistola, L., Chiari, R., Minotti, V., Colella, R., Giuffrida, D., Tofanetti, F. R., Siggillino, A., Flacco, A., et al. (2011) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e31820a3a6b · Cited by 177
An, S.-J., Chen, Z.-H., Su, J., Zhang, X.-C., Zhong, W.-Z., Yang, J.-J., Zhou, Q., Yang, X.-N., Huang, L., Guan, J.-L., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0040109 · Cited by 176
Shih, J., Gow, C., Yu, C., Yang, C., Chang, Y., Tsai, M., Hsu, Y., Chen, K., Su, W., & Yang, P. (2006) · International Journal of Cancer · doi:10.1002/ijc.21458 · Cited by 170
Detection of K-ras mutations in lung carcinomas: Relationship to prognosis
(1996) · Lung Cancer · doi:10.1016/s0169-5002(96)80041-9 · Cited by 168
Sun, P.-L., Seol, H., Lee, H. J., Yoo, S. B., Kim, H., Xu, X., Jheon, S., Lee, C.-T., Lee, J.-S., & Chung, J.-H. (2012) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e3182381515 · Cited by 163
Toyooka, S., Tokumo, M., Shigematsu, H., Matsuo, K., Asano, H., Tomii, K., Ichihara, S., Suzuki, M., Aoe, M., Date, H., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-2625 · Cited by 163
Sequist, L. V., Joshi, V. A., Jänne, P. A., Muzikansky, A., Fidias, P., Meyerson, M., Haber, D. A., Kucherlapati, R., Johnson, B. E., & Lynch, T. J. (2007) · The Oncologist · doi:10.1634/theoncologist.12-1-90 · Cited by 162
Clinicopathologic implication of ALK rearrangement in surgically resected lung cancer
Paik, J. H., Choi, C., Kim, H., Jang, S. J., Choe, G., Kim, D. K., Kim, H. J., Yoon, H.-I., Lee, C., Jheon, S., et al. (2011) · Lung Cancer · doi:10.1016/j.lungcan.2011.11.008 · Cited by 154
Gahr, S., Stoehr, R., Geissinger, E., Ficker, J. H., Brueckl, W. M., Gschwendtner, A., Gattenloehner, S., Fuchs, F. S., Schulz, C. K. J., Rieker, R. J., et al. (2013) · British Journal of Cancer · doi:10.1038/bjc.2013.511 · Cited by 150
Kim, H. R., Shim, H. S., Chung, J.-H., Lee, Y. J., Hong, Y. K., Rha, S. Y., Kim, S. H., Ha, S., Kim, S. K., Chung, K. S., et al. (2011) · Cancer · doi:10.1002/cncr.26311 · Cited by 149
Yang, S. H., Mechanic, L. E., Yang, P., Landi, M. T., Bowman, E. D., Wampfler, J. A., Meerzaman, D. M., Hong, K. M., Mann, F., Dracheva, T., et al. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-1853 · Cited by 146
Husgafvel‐Pursiainen, K., Hackman, P., Ridanpää, M., Anttila, S. L., Karjalainen, A., Partanen, T. J., Taikina-aho, O., Heikkilä, L. J., & Vainio, H. (1993) · International Journal of Cancer · doi:10.1002/ijc.2910530213 · Cited by 145
Sugio, K., Uramoto, H., Ono, K., Oyama, T., Hanagiri, T., Sugaya, M., Ichiki, Y., So, T., Nakata, S., Morita, M., et al. (2006) · British Journal of Cancer · doi:10.1038/sj.bjc.6603040 · Cited by 141
Frequency of EGFR Mutations in 907 Lung Adenocarcioma Patients of Indian Ethnicity
Chougule, A., Prabhash, K., Noronha, V., Joshi, A., Thavamani, A., Chandrani, P., Upadhyay, P., Utture, S., Desai, S. R., Jambhekar, N. A., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0076164 · Cited by 136
Molecular genetics of lung cancer in people who have never smoked
Subramanian, J., & Govindan, R. (2008) · The Lancet Oncology · doi:10.1016/s1470-2045(08)70174-8 · Cited by 134
Clinicopathologic Characteristics of the EGFR Gene Mutation in Non–small Cell Lung Cancer
Tsao, A. S., Tang, X., Sabloff, B. S., Xiao, L., Shigematsu, H., Roth, J. A., Spitz, M. R., Hong, W. K., Gazdar, A. F., & Wistuba, I. I. (2006) · Journal of Thoracic Oncology · doi:10.1016/s1556-0864(15)31573-2 · Cited by 132
Tomizawa, Y., Iijima, H., Sunaga, N., Sato, K., Takise, A., Otani, Y., Tanaka, S., Suga, T., Saito, R., Ishizuka, T., et al. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-0441 · Cited by 131
Villaruz, L. C., Socinski, M. A., Abberbock, S. R., Berry, L. D., Johnson, B. E., Kwiatkowski, D. J., Iafrate, A. J., Varella‐Garcia, M., Franklin, W. A., Camidge, D. R., et al. (2014) · Cancer · doi:10.1002/cncr.29042 · Cited by 130
p53 and K-ras mutations in lung cancers from former and never-smoking women.
Vähäkangas, K., Bennett, W. P., Castrén, K., Welsh, J. A., Ma, K., Blömeke, B., Alavanja, M. C. R., & Harris, C. C. (2001) · PubMed · Cited by 128
Suzuki, M., Shigematsu, H., Iizasa, T., Hiroshima, K., Nakatani, Y., Minna, J. D., Gazdar, A. F., & Fujisawa, T. (2006) · Cancer · doi:10.1002/cncr.21853 · Cited by 127
Sakuma, Y., Matsukuma, S., Yoshihara, M., Nakamura, Y., Noda, K., Nakayama, H., Kameda, Y., Tsuchiya, E., & Miyagi, Y. (2007) · American Journal of Clinical Pathology · doi:10.1309/wvxfgaflaux48du6 · Cited by 125
Smits, A. J. J., Kummer, J. A., Hinrichs, J. W. J., Herder, G. J. M., Scheidel, K. C., Jiwa, N. M., Ruijter, T. E. G., Nooijen, P. T. G. A., Looijen-Salamon, M. G., Ligtenberg, M. J. L., et al. (2012) · Cellular Oncology · doi:10.1007/s13402-012-0078-4 · Cited by 121
Genotyping Non-small Cell Lung Cancer (NSCLC) in Latin America
Arrieta, O. G., Cardona, A. F., Bramuglia, G. F., Gallo, A., Campos-Parra, A. D., Serrano, S., Castro, M., Avilés, A., Amorín, E., Kirchuk, R., et al. (2011) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e31822f655f · Cited by 120
Hsieh, R.-K., Lim, K., Kuo, H.-T., Tzen, C., & Huang, M.-J. (2005) · CHEST Journal · doi:10.1378/chest.128.1.317 · Cited by 120
Li, Y., Li, Y., Yang, T., Wei, S., Wang, J., Wang, M., Wang, Y., Zhou, Q., Liu, H., & Chen, J. (2013) · PLoS ONE · doi:10.1371/journal.pone.0052093 · Cited by 116
Prognostic value ofTP53,KRASandEGFRmutations in nonsmall cell lung cancer: the EUELC cohort
Scoccianti, C., Vesin, A., Martel, G., Olivier, M., Brambilla, E. M., Timsit, J., Tavecchio, L., Brambilla, C., Field, J. K., & Hainaut, P. L. (2012) · European Respiratory Journal · doi:10.1183/09031936.00097311 · Cited by 116
Nomogram to predict the presence ofEGFRactivating mutation in lung adenocarcinoma
Girard, N., Sima, C. S., Jackman, D. M., Sequist, L. V. D., Chen, H., Yang, J. C., Ji, H., Waltman, B. A., Rosell, R., Tarón, M., et al. (2011) · European Respiratory Journal · doi:10.1183/09031936.00010111 · Cited by 113
Fukui, T., Yatabe, Y., Kobayashi, Y., Tomizawa, K., Ito, S., Hatooka, S., Matsuo, K., & Mitsudomi, T. (2012) · Lung Cancer · doi:10.1016/j.lungcan.2012.03.013 · Cited by 111
Screening for EGFR mutations in lung cancer, a report from India
Sahoo, R., Harini, V. V., Babu, V. C., Okaly, G. V. P., Rao, S., Nargund, A. R., Venkataswamy, E., Rao, R., & Kumar, B. S. (2011) · Lung Cancer · doi:10.1016/j.lungcan.2011.01.004 · Cited by 111
Warth, A., Penzel, R., Lindenmaier, H., Brandt, R., Stenzinger, A., Herpel, E., Goeppert, B. F., Thomas, M., Herth, F. J. F., Dienemann, H., et al. (2013) · European Respiratory Journal · doi:10.1183/09031936.00018013 · Cited by 111
Clinicopathological predictors of EGFR/KRAS mutational status in primary lung adenocarcinomas
Đačić, S., Shuai, Y., Yousem, S. A., Ohori, P. N., & Nikiforova, M. N. (2009) · Modern Pathology · doi:10.1038/modpathol.2009.154 · Cited by 110
Lung cancer in never smokers: Change of a mindset in the molecular era
Lee, Y. J., Kim, J.-H., Kim, S. I., Ha, S., Mok, T. S. K., Mitsudomi, T., & Cho, B. C. (2011) · Lung Cancer · doi:10.1016/j.lungcan.2010.12.013 · Cited by 109
Mounawar, M., Mukeria, A., Calvez‐Kelm, F. L., Hung, R. J., Renard, H., Cortot, A. B., Bollart, C., Zaridze, D. G., Brennan, P., Boffetta, P., et al. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-4229 · Cited by 108
Pulling, L. C., Divine, K. K., Klinge, D. M., et al. (2003) · PubMed · Cited by 108
Gealy, R., Zhang, L., Siegfried, J. M., Luketich, J. D., & Keohavong, P. (1999) · PubMed · Cited by 107
Takano, T., Ohe, Y., Tsuta, K., Fukui, T., Sakamoto, H., Yoshida, T., Tateishi, U., Nokihara, H., Yamamoto, N., Sekine, I., et al. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-0627 · Cited by 105
Lee, S. Y., Kim, M. J., Jin, G., Yoo, S. S., Park, J. Y., Choi, J. E., Jeon, H. S., Cho, S., Lee, E. B., Cha, S. I., et al. (2010) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e3181f0beca · Cited by 102
Correlation between morphology and EGFR mutations in lung adenocarcinomas
Ninomiya, H., Hiramatsu, M., Inamura, K., Nomura, K., Okui, M., Miyoshi, T., Okumura, S., Satoh, Y., Nakagawa, K., Nishio, M., et al. (2008) · Lung Cancer · doi:10.1016/j.lungcan.2008.04.017 · Cited by 99
Mutational analysis of EGFR and K-RAS genes in lung adenocarcinomas
Soung, Y. H., Lee, J. W., Kim, S. Y., Seo, S. H., Park, W. S., Nam, S. W., Song, S. Y., Han, J. H., Park, C. K., Lee, J. Y., et al. (2005) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/s00428-005-1254-y · Cited by 98
Spectrum of LKB1, EGFR, and KRAS Mutations in Chinese Lung Adenocarcinomas
Gao, B., Sun, Y., Zhang, J., Ren, Y., Fang, R., Han, X., Shen, L., Liu, X., Pao, W. J., Chen, H., et al. (2010) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e3181e05016 · Cited by 98
Zhang, X.-T., Li, L.-Y., Mu, X. L., Cui, Q.-C., Chang, X.-Y., Song, W., Wang, S., Wang, M., Zhong, W., & Zhang, L. (2005) · Annals of Oncology · doi:10.1093/annonc/mdi340 · Cited by 96
Blons, H., Côté, J.-F., Corre, D. L., Riquet, M., Fabre, E., Laurent‐Puig, P., & Danel, C. J. (2006) · The American Journal of Surgical Pathology · doi:10.1097/01.pas.0000213285.65907.31 · Cited by 93
Jung, H. S., Park, D. K., Kim, M. J., Yu, S. K., Kwon, K. A., Ku, Y. S., Kim, Y. K., & Kim, J. H. (2009) · The Korean Journal of Internal Medicine · doi:10.3904/kjim.2009.24.1.43 · Cited by 93
Dasgupta, S., Soudry, E., Mukhopadhyay, N. D., Shao, C., Yee, J., Lam, S., Lam, W. L., Zhang, W. Y., Gazdar, A. F., Fisher, P. B., et al. (2011) · Journal of Cellular Physiology · doi:10.1002/jcp.22980 · Cited by 92
Kim, Y. T., Seong, Y. W., Jung, Y. J., Jeon, Y. K., Park, I. K., Kang, C. H., & Kim, J. H. (2013) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e318277a3bb · Cited by 91
Prognostic and Predictive Value of KRAS Mutations in Advanced Non-Small Cell Lung Cancer
Sun, J., Hwang, D. W., Ahn, J. S., Ahn, M., & Park, K. (2013) · PLoS ONE · doi:10.1371/journal.pone.0064816 · Cited by 91
Bauml, J. M., Mick, R., Zhang, Y., Watt, C. D., Vachani, A., Aggarwal, C., Evans, T. L., & Langer, C. J. (2013) · Lung Cancer · doi:10.1016/j.lungcan.2013.05.011 · Cited by 91
Pallis, A. G., Voutsina, A., Kalikaki, A., Souglakos, J., Briasoulis, E. C., Murray, S. J., Koutsopoulos, A. V., Tripaki, M., Stathopoulos, E. N., Mavroudis, D., et al. (2007) · British Journal of Cancer · doi:10.1038/sj.bjc.6604068 · Cited by 90
Matsuo, K., Ito, H. M., Yatabe, Y., Hiraki, A., Hirose, K., Wakai, K., Kosaka, T., Suzuki, T., Tajima, K., & Mitsudomi, T. (2006) · Cancer Science · doi:10.1111/j.1349-7006.2006.00347.x · Cited by 89
Toyooka, S., Matsuo, K., Shigematsu, H., Kosaka, T., Tokumo, M., Yatabe, Y., Ichihara, S., Inukai, M., Suehisa, H., Soh, J., et al. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-0216 · Cited by 89
Noronha, V., Prabhash, K., Thavamani, A., Chougule, A., Purandare, N. C., Joshi, A., Sharma, R., Desai, S. R., Jambekar, N., Dutt, A., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0061561 · Cited by 85
Wu, C., Hsu, H., Liu, H., Chang, J. W., Chen, Y., Hsieh, W.-Y., Hsieh, J., Hsieh, M., Chen, Y., & Huang, S. (2008) · Cancer · doi:10.1002/cncr.23925 · Cited by 82
Coté, M. L., Haddad, R., Edwards, D. J., Atikukke, G., Gadgeel, S. M., Soubani, A. O., Lonardo, F., Bepler, G., Schwartz, A. G., & Ethier, S. P. (2011) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e31820a0ec0 · Cited by 81
Comparison of gefitinib and erlotinib in advanced NSCLC and the effect of EGFR mutations
Wu, J., Wu, S., Yang, C.-H., Chang, Y., Chang, Y., Hsu, Y.-C., Shih, J., & Yang, P. (2010) · Lung Cancer · doi:10.1016/j.lungcan.2010.08.013 · Cited by 80
Choi, Y., Sun, J., Cho, J., Rampal, S., Han, J., Parasuraman, B. M., Güallar, E., Lee, G., Lee, J., & Shim, Y. M. (2013) · PLoS ONE · doi:10.1371/journal.pone.0056011 · Cited by 79
Lim, E. H., Zhang, S.-L., Li, J., Yap, W. S., Howe, T.-C., Tan, B. P., Lee, Y.-S., Wong, D., Khoo, K., Seto, K., et al. (2009) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e3181913e28 · Cited by 77
Cserepes, M., Ostoros, G., Lohinai, Z., Rásó, E., Barbai, T., Tímár, J., Rózsás, A., Moldvay, J., Kovalszky, I., Fábián, K., et al. (2014) · European Journal of Cancer · doi:10.1016/j.ejca.2014.04.001 · Cited by 77
Prognostic value of KRAS mutations and Ki-67 expression in stage I lung adenocarcinomas
Woo, T., Okudela, K., Yazawa, T., Wada, N., Ogawa, N., Ishiwa, N., Tajiri, M., Rino, Y., Kitamura, H., & Masuda, M. (2009) · Lung Cancer · doi:10.1016/j.lungcan.2008.11.020 · Cited by 76
Tsao, M., Sakurada, A., Ding, K., Aviel‐Ronen, S., Ludkovski, O., Liu, G., Maître, A. L., Gandara, D. R., Johnson, D. H., Rigas, J. R., et al. (2010) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e3181fd83a4 · Cited by 76
Serizawa, M., Koh, Y., Kenmotsu, H., Isaka, M., Murakami, H., Akamatsu, H., Mori, K. P., Abe, M., Hayashi, I., Taira, T., et al. (2014) · Cancer · doi:10.1002/cncr.28604 · Cited by 74
Yokoyama, T., Kondo, M., Gotô, Y., Fukui, T., Yoshioka, H., Yokoi, K., Osada, H., Imaizumi, K., Hasegawa, Y., Shimokata, K., et al. (2006) · Cancer Science · doi:10.1111/j.1349-7006.2006.00233.x · Cited by 74
Cadranel, J. L., Mauguen, A., Beau‐Faller, M., Zalcman, G., Buisine, M., Westeel, V., Longchampt, É., Wislez, M., Coudert, B. P., Daniel, C., et al. (2012) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e318265b2b5 · Cited by 73
Martínez, P., Hernández‐Losa, J., Montero, M. Á., Cedrés, S., Castellví, J., Martínez‐Martí, A., Tallada, N., Murtra-Garrell, N., Navarro-Mendivill, A., Rodríguez-Freixinós, V., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0052261 · Cited by 73
Oncogenic driver mutations in patients with non-small-cell lung cancer at various clinical stages
Zhou, J. X., Yang, H., Deng, Q., Gu, X., He, P., Lin, Y., Zhao, M., Jiang, J., Chen, H., Lin, Y., et al. (2013) · Annals of Oncology · doi:10.1093/annonc/mds626 · Cited by 73
Clinical significance of BRAF gene mutations in patients with non-small cell lung cancer.
Kobayashi, M., Sonobe, M., Takahashi, T., Yoshizawa, A., Ishikawa, M., Kikuchi, R., Okubo, K., Huang, C., & Date, H. (2011) · PubMed · Cited by 70
Lee, Y. J., Park, I. K., Park, M. S., Choi, H. J., Cho, B. C., Chung, K. S., Kim, S. K., Chang, J., Moon, J. W., Kim, H., et al. (2009) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-009-0611-7 · Cited by 69
The prevalence of EGFR mutations in non‐small cell lung cancer in an unselected Caucasian population
Skov, B. G., Høgdall, E. V. S., Clementsen, P. F., Krasnik, M., Larsen, K. R., Sørensen, J. B., Skov, T., & Mellemgaard, A. (2014) · Apmis · doi:10.1111/apm.12328 · Cited by 69
Haneda, H., Sasaki, H., Lindeman, N. I., Kawano, O., Endo, K., Suzuki, E., Shimizu, S., Yukiue, H., Kobayashi, Y., Yano, M., et al. (2006) · Japanese Journal of Clinical Oncology · doi:10.1093/jjco/hyi228 · Cited by 66
EGFR and KRAS Mutations in Patients With Adenocarcinoma of the Lung
Jang, T. W., Oak, C. H., Chang, H. K., Suo, S. J., & Jung, M. H. (2009) · The Korean Journal of Internal Medicine · doi:10.3904/kjim.2009.24.1.48 · Cited by 65
Clinicopathological features of lung adenocarcinoma with KRAS mutations
Kakegawa, S., Shimizu, K., Sugano, M., Miyamae, Y., Kaira, K., Araki, T., 中野, 哲., Kamiyoshihara, M., Kawashima, O., & Takeyoshi, I. (2011) · Cancer · doi:10.1002/cncr.26010 · Cited by 62
A novel molecular staging protocol for non-small cell lung cancer
Miyake, M., Adachi, M., Huang, C., Higashiyama, M., Kodama, K., & Taki, T. (1999) · Oncogene · doi:10.1038/sj.onc.1202556 · Cited by 60
Bao Ming, Q. I. N., Chen, X., Zhu, J., et al. (2005) · Cell Research · doi:10.1038/sj.cr.7290289 · Cited by 57
Prospective screening for ALK: Clinical features and outcome according to ALK status
Fallet, V., Cadranel, J. L., Doubre, H., Toper, C., Monnet, I., Chinet, T., Oliviero, G., Foulon, G., de Crémoux, H., Vieira, T., et al. (2014) · European Journal of Cancer · doi:10.1016/j.ejca.2014.02.001 · Cited by 57
Analysis ofEGFR,EML4-ALK,KRAS, andc-METmutations in Chinese lung adenocarcinoma patients
Xia, N., An, J., Jiang, Q., Li, M., Tan, J., & Hu, C. (2013) · Experimental Lung Research · doi:10.3109/01902148.2013.819535 · Cited by 57
Yamaguchi, N., VanderLaan, P. A., Folch, E. E., Boucher, D. H., Canepa, H. M., Kent, M. S., Gangadharan, S. P., Majid, A., Kocher, O. N., Goldstein, M. A., et al. (2013) · Lung Cancer · doi:10.1016/j.lungcan.2013.07.013 · Cited by 56
Zimmer, S., Kahl, P., Buhl, T., Steiner, S., Wardelmann, E., Merkelbach‐Bruse, S., Buettner, R., & Heukamp, L. C. (2008) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-008-0509-9 · Cited by 54
Nras and Kras mutation in Japanese lung cancer patients: Genotyping analysis using LightCycler
Sasaki, H., Okuda, K., Kawano, O., Endo, K., Yukiue, H., Yokoyama, T., Yano, M., & Fujii, Y. (2007) · Oncology Reports · doi:10.3892/or.18.3.623 · Cited by 52
Zhang, H., Liu, D., Li, S., Zheng, Y.-Q., Yang, X., Li, X., Zhang, Q., Qin, N., Lu, J., Ren‐Heidenreich, L., et al. (2013) · Journal of Molecular Diagnostics · doi:10.1016/j.jmoldx.2013.06.006 · Cited by 52
Bonanno, L., Schiavon, M., Nardo, G., Bertorelle, R., Bonaldi, L., Galligioni, A., Indraccolo, S., Pasello, G., Rea, F., & Favaretto, A. G. (2010) · PubMed · Cited by 52
Marchetti, A., Pellegrini, S., Sozzi, G., Bertacca, G., Gaeta, P., Buttitta, F., Carnicelli, V., Griseri, P., Chella, A., Angeletti, C. A., et al. (1998) · British Journal of Cancer · doi:10.1038/bjc.1998.445 · Cited by 49
Satouchi, M., Negoro, S., Funada, Y., Urata, Y., Shimada, T., Yoshimura, S., Kotani, Y., Sakuma, T., Watanabe, H., Adachi, S., et al. (2007) · British Journal of Cancer · doi:10.1038/sj.bjc.6603710 · Cited by 49
Epidermal growth factor receptor and KRAS mutations in Brazilian lung cancer patients
Bacchi, C. E., Ciol, H., Queiroga, E., Benine, L. C., Silva, L. H., & Ojopi, E. P. B. (2012) · Clinics · doi:10.6061/clinics/2012(05)03 · Cited by 49
Reinmuth, N., Jauch, A. S., Xu, E. C., Muley, T., Granzow, M., Hoffmann, H., Dienemann, H., Herpel, E., Schnabel, P. A., Herth, F. J. F., et al. (2008) · Lung Cancer · doi:10.1016/j.lungcan.2008.03.011 · Cited by 48
High Efficacy of First-Line Gefitinib in Non-Asian Patients with EGFR-Mutated Lung Adenocarcinoma
Moiseyenko, V. M., Procenko, S. A., Levchenko, E., As, B., Moiseenko, F. V., Iyevleva, A. G., Mitiushkina, N. V., Togo, A. V., Semionov, I. I., Ivantsov, A. O., et al. (2010) · Onkologie · doi:10.1159/000302729 · Cited by 48
Cai, X., Sheng, J., Tang, C., Nandakumar, V., Ye, H., Ji, H. L., Tang, H., Yu, Q., Guan, H., Lou, F., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0095228 · Cited by 47
Choi, Y. H., Lee, J. K., Kang, H. J., Lee, T. S., Kim, C. H., Kim, C. H., Koh, J. S., Baek, H. J., Lee, J. C., & Na, I. I. (2010) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e3181f38816 · Cited by 47
Lai, Y., Zhang, Z., Li, J., Sun, D. I., Zhou, Y., Jiang, T., Han, Y., Huang, L., Zhu, Y., Li, X., et al. (2013) · International Journal of Molecular Sciences · doi:10.3390/ijms141224549 · Cited by 46
Epidermal growth factor receptor mutation in lung adenocarcinoma in India: A single center study
Doval, D. C., Choudhury, K. D., Talwar, V., Gupta, S., Mehta, A., Azam, S., & Batra, U. (2013) · Journal of Carcinogenesis · doi:10.4103/1477-3163.114970 · Cited by 46
Errihani, H. H., Inrhaoun, H., Boukir, A., Kettani, F., Gamra, L., Mestari, A., Jabri, L., Bensouda, Y., M’rabti, H., & Elghissassi, I. (2013) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e31829f6b4a · Cited by 45
EGFR Gene Alterations in a Norwegian Cohort of Lung Cancer Patients Selected for Surgery
Helland, Å., Skaug, H. M., Kleinberg, L., Lund‐Iversen, M., Rud, A. K., Fleischer, T., Sagerup, C., Solberg, S. K., Jørgensen, L. H., Ariansen, S. L., et al. (2011) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e31820db209 · Cited by 44
Weber, B., Hager, H., Sørensen, B. S., McCulloch, T., Mellemgaard, A., Khalil, A. A., Nexø, E., & Meldgaard, P. (2013) · Lung Cancer · doi:10.1016/j.lungcan.2013.11.023 · Cited by 43
Xu, J., Han, Y., Duan, H. Q., Gao, E., Zhang, Y., Liu, X., Zhang, J. S., Toschi, L., Galetta, D., Azzariti, A., et al. (2008) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-008-0512-1 · Cited by 43
Andujar, P., Pairon, J. ‐., Renier, A., Descatha, A., Hysi, I., Abd‐Alsamad, I., Billon‐Galland, M., Blons, H., Clin, B., Danel, C. J., et al. (2013) · Mutagenesis · doi:10.1093/mutage/get008 · Cited by 43
Lung cancer in 'Never-smokers': a unique entity.
Subramanian, J., & Govindan, R. (2010) · PubMed · Cited by 42
Molecular alterations in non–small cell lung carcinomas of the young
VandenBussche, C. J., Illei, P. B., Lin, M., Ettinger, D. S., & Maleki, Z. (2014) · Human Pathology · doi:10.1016/j.humpath.2014.08.005 · Cited by 42
Takeda, M., Okamoto, I., Sakai, K., Kawakami, H., Nishio, K., & Nakagawa, K. (2012) · Annals of Oncology · doi:10.1093/annonc/mds124 · Cited by 42
Wang, J., Dong, Y., Cai, Y., Zhou, L., Wu, S., Liu, G., Su, D., Li, X., Qin, N., Nong, J., et al. (2014) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-014-1584-8 · Cited by 41
Mutation and Polymorphism in the EGFR-TK Domain Associated with Lung Cancer
Zhang, W., Stabile, L. P., Keohavong, P., Romkes, M., Grandis, J. R., Traynor, A. M., & Siegfried, J. M. (2006) · Journal of Thoracic Oncology · doi:10.1016/s1556-0864(15)30375-0 · Cited by 40
Impact of age on epidermal growth factor receptor mutation in lung cancer
Ueno, T., Toyooka, S., Suda, K., Soh, J., Yatabe, Y., Miyoshi, S., Matsuo, K., & Mitsudomi, T. (2012) · Lung Cancer · doi:10.1016/j.lungcan.2012.09.006 · Cited by 40
EGFR mutations and human papillomavirus in lung cancer
Kato, T., Koriyama, C., Khan, N., Samukawa, T., Yanagi, M., Hamada, T., Yokomakura, N., Otsuka, T., Inoue, H., Sato, M., et al. (2012) · Lung Cancer · doi:10.1016/j.lungcan.2012.08.011 · Cited by 39
Yanagawa, N., Tamura, G., Oizumi, H., Endoh, M., Sadahiro, M., & Motoyama, T. (2011) · PubMed · Cited by 39
Epidermal Growth Factor Receptor Mutations in Lung Adenocarcinoma in Malaysian Patients
Liam, C. K., Wahid, M. I. A., Rajadurai, P., Cheah, Y. K., & Ng, T. S. (2013) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e31828b5228 · Cited by 37
Wang, Y., Lee, H.-S., Chen, S.-K., Yang, S.-C., & Chen, C. (1998) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s004320050208 · Cited by 36
Đačić, S. (2013) · Journal of Clinical Pathology · doi:10.1136/jclinpath-2012-201336 · Cited by 36
Kim, T. J., Park, C. K., Yeo, C. D., Park, K., Rhee, C. K., Kim, J., Kim, S. J., Lee, S. H., Lee, K. Y., & Yoon, H. K. (2014) · Journal of Surgical Oncology · doi:10.1002/jso.23646 · Cited by 35
The status of KRAS mutations in patients with non-small cell lung cancers from mainland China
Lü (2009) · Oncology Reports · doi:10.3892/or_00000529 · Cited by 34
Murray, S. J., Timotheadou, E. T., Linardou, H., Vrettou, A. V., Kostopoulos, I. S., Skřičková, J., Papakostantinou, C., Christodoulou, C., Pectasides, D. G., Samantas, E., et al. (2006) · Lung Cancer · doi:10.1016/j.lungcan.2005.12.015 · Cited by 33
Yamaguchi, F., Kugawa, S., Tateno, H., Kokubu, F., & Fukuchi, K. (2012) · Lung Cancer · doi:10.1016/j.lungcan.2012.08.014 · Cited by 33
He, Y., Li, S., Ren, S., Cai, W., Li, X., Zhao, C., Li, J., Chen, X., Gao, G., Li, W., et al. (2013) · Lung Cancer · doi:10.1016/j.lungcan.2013.05.004 · Cited by 31
de Mello, R. A., Pires, F. S., Marques, D. S., Oliveira, J., Rodrigues, A., Soares, M., Azevedo, I., Peixoto, A., Santos, C., Pinto, C., et al. (2012) · Tumor Biology · doi:10.1007/s13277-012-0465-5 · Cited by 31
Okazaki, I., Ishikawa, S., & Sohara, Y. (2014) · PubMed · Cited by 31
Fontanini, G. (2009) · Oncology Reports · doi:10.3892/or_00000488 · Cited by 30
Inequalities in lung cancer: a world ofEGFR
Carbonnaux, M., Souquet, P.-J., Meert, A., Scherpereel, A., Peters, M. J., & Couraud, S. (2016) · European Respiratory Journal · doi:10.1183/13993003.01157-2015 · Cited by 30
Koga, T., Takeshita, M., Yano, T., Maehara, Y., & Sueishi, K. (2010) · International Journal of Cancer · doi:10.1002/ijc.25447 · Cited by 29
Lee, Y. J., Shim, H. S., Kang, Y. A., Hong, S. J., Kim, H. K., Kim, H., Kim, Y. S., Choi, S. H., Kim, J.-H., & Cho, B. C. (2010) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-010-0853-4 · Cited by 29
Epidermal Growth Factor Receptor Mutations in 510 Finnish Non–Small-Cell Lung Cancer Patients
Mäki‐Nevala, S., Rönty, M. J., Morel, M., Gómez-Hernández, M. T., Dawson, Z., Sarhadi, V. K., Telaranta-Keerie, A., Knuuttila, A., & Knuutila, S. (2014) · Journal of Thoracic Oncology · doi:10.1097/jto.0000000000000132 · Cited by 26
Lung cancers unrelated to smoking: characterized by single oncogene addiction?
Suda, K., Tomizawa, K., Yatabe, Y., & Mitsudomi, T. (2011) · International Journal of Clinical Oncology · doi:10.1007/s10147-011-0262-y · Cited by 25
The Clinical Relevance of Pathologic Subtypes in Metastatic Lung Adenocarcinoma
Clay, T. D., Do, H., Sundararajan, V., Moore, M. M., Conron, M., Wright, G. M., McLachlan, S., Dobrovic, A., & Russell, P. A. (2014) · Journal of Thoracic Oncology · doi:10.1097/jto.0000000000000150 · Cited by 24
EGFR and KRAS mutations in Turkish non-small cell lung cancer patients: a pilot study
Bircan, S., Baloğlu, H., Küçükodacı, Z., & Bircan, A. (2014) · Medical Oncology · doi:10.1007/s12032-014-0087-4 · Cited by 23
Kim, H. R., Ahn, J. R., Lee, J. G., Bang, D. H., Ha, S., Hong, Y. K., Kim, S. M., Nam, K. C., Rha, S. Y., Soo, R. A., et al. (2013) · Yonsei Medical Journal · doi:10.3349/ymj.2013.54.4.865 · Cited by 23
Comprehensive Analysis of Epidermal Growth Factor Receptor Gene Status in Lung Adenocarcinoma
Li, C., Sun, Y., Fang, Z., Han, X., Fang, R., Zhang, Y., Pan, Y., Zhang, W., Ren, Y., Ji, H., et al. (2011) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e318215a4f2 · Cited by 21
Ragusa, M., Vannucci, J., Ludovini, V., Bianconi, F., Treggiari, S., Tofanetti, F. R., Flacco, A., Colella, R., Sidoni, A., Crinò, L., et al. (2013) · American Journal of Clinical Oncology · doi:10.1097/coc.0b013e31827a7e7a · Cited by 21
Castro, A. S., Parente, B., Gonçalves, I., Antunes, A., Barroso, A., Conde, S., Neves, S., & Machado, J. C. (2012) · Revista Portuguesa de Pneumologia · doi:10.1016/j.rppneu.2012.08.002 · Cited by 17
Uramoto, H., So, T., Nagata, Y., Kuroda, K., Shigematsu, Y., Baba, T., So, T., Takenoyama, M., Hanagiri, T., & Yasumoto, K. (2010) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e3181e0b993 · Cited by 17
Genetic Mutation Screen in Early Non–Small-Cell Lung Cancer (NSCLC) Specimens
Bar, J., Damianovich, M., Hout‐Siloni, G., Dar, E., Cohen, Y., Perelman, M., Nun, A. B., Simansky, D. A., Yellin, A., Urban, D., et al. (2013) · Clinical Lung Cancer · doi:10.1016/j.cllc.2013.11.005 · Cited by 16
Zhang, L.-J., Cai, L., Li, Z., Wang, W.-P., Guo, K., Shao, J., Wang, J.-Y., Yu, H. M., & Rong, T.-H. (2012) · 癌症:英文版 · doi:10.5732/cjc.011.10409 · Cited by 14
Development of a rapid and practical mutation screening assay for human lung adenocarcinoma
Jablons, D. M. (2012) · International Journal of Oncology · doi:10.3892/ijo.2012.1396 · Cited by 7
EGFR mutations in patients with non small-cell lung cancer in Bulgaria and treatment with gefitinib.
Damyanov, D., Koynov, K. D., Naseva, E., & Bichev, S. (2015) · PubMed · Cited by 5
Cited by
Proteogenomic Characterization Reveals Therapeutic Vulnerabilities in Lung Adenocarcinoma
Gillette, M. A., Satpathy, S., Cao, S., Dhanasekaran, S. M., Vasaikar, S. V., Krug, K., Petralia, F., Li, Y., Liang, W.-W., Reva, B., et al. (2020) · Cell · doi:10.1016/j.cell.2020.06.013 · Cited by 820
Pan-cancer circulating tumor DNA detection in over 10,000 Chinese patients
Zhang, Y., Yao, Y., Xu, Y., Li, L., Gong, Y., Zhang, K., Zhang, M., Guan, Y., Chang, L., Xia, X., et al. (2021) · Nature Communications · doi:10.1038/s41467-020-20162-8 · Cited by 300
Cheng, C., Sun, L., Yang, J., Liu, Z., Zhang, F., Qiu, L., Yu, M., Wang, T., Huang, J., Wang, L., et al. (2026) · Nature Communications · doi:10.1038/s41467-026-73682-0
Metadata
- Authors
- Chapman, A. M., Sun, K. Y., Ruestow, P., Cowan, D. M., & Madl, A. K.
- Venue
- Lung Cancer
- Publisher
- Elsevier BV
- Published
- 2016-12
- Volume
- 102
- Pages
- 122-134
- ISSN
- 0169-5002 (ISSN-L)
- OpenAlex
- W2534193912
- Cited by
- 261
- References
- 186
- FWCI
- 9.53
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.